$0.594
-0.255 (-42.92%)At close
XTKG News
XTKG Events
X3 Holdings Trading Halted, News Pending
X3 Holdings Co Ltd trading halted, news pending
X3 Holdings Approves 30-for-1 Share Consolidation
X3 Holdings approved a consolidation of its Class A ordinary shares on a 30-to-1 basis. The company's Class A shares are expected to begin trading on a post consolidation basis on March 5. As a result of the consolidation, each 30 pre-consolidation Class A shares of the company will be automatically combined into one Class A share, without any action on the part of the holders, with par value of the Class A shares of the company being changed from $0.00003 per share to $0.0009 per share, and the company's issued and outstanding Class A shares will be reduced from 54,238,270 to approximately 1,807,943. The company's Class A shares will continue to trade on Nasdaq under the symbol "XTKG" under a new CUSIP number - G72007159.The Share Consolidation is intended to increase the market price per share of the company's Class A shares to allow the company to maintain its Nasdaq listing.
X3 Holdings Enters Strategic Agreement with AI Healthcare Tech Company
X3 Holdings has entered into a strategic agreement with an AI healthcare technology company relating to the global operations of an AI-powered healthcare smartwatch. Under the partnership, X3 Holdings will support the smartwatch's international commercialization and global operational deployment, marking the company's entry into the AI healthcare sector. The smartwatch is positioned as an AI-powered neuro-digital health device designed to shift healthcare from passive treatment to proactive health management. Through real-time signal capture and dynamic modulation, the system establishes a closed-loop cycle of monitoring, analysis, adjustment, and feedback without reliance on invasive procedures or pharmaceuticals. The smartwatch operates on a large-scale health data platform constructed from 7 million user records and 25,000 physiological indicators. The product is developed by the partner with expertise in non-invasive brain-computer interface applications and digital neuro-health systems. The company expects the first service contract under this strategic collaboration to generate revenue beginning in March 2026, subject to the execution of commercial agreements and rollout timelines.
X3 Holdings Trading Halted, News Pending
X3 Holdings Co Ltd trading halted, news pending
X3 Holdings regains compliance with Nasdaq minimum bid price deficiency
X3 Holdings announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market dated April 11, 2025, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) and the matter is closed. As previously announced, the Company received a notification letter from the Nasdaq dated April 10, 2024, indicating its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Minimum Bid Price Requirement. Pursuant to the Nasdaq Listing Rules 5810(c)(3)(A), the Company was provided with 180 calendar days, and has further received an extension of 180 calendar days, to April 7, 2025, in order to regain compliance with the Minimum Bid Price Requirement. Pursuant to the Compliance Notice, the Company evidenced a closing bid price of its ordinary shares at or greater than $1.00 per share for 10 consecutive business days from March 17, 2025 to April 11, 2025. Thus, the Company has regained compliance with the Minimum Bid Price Requirement, and the matter is closed.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。